BCR-ABL Kinase Domain (KD) Mutations IRMA

The BCR-ABL Kinase Domain (KD) Mutations IRMA test is an important diagnostic tool. This test helps detect mutations in the BCR-ABL kinase domain, which are important for identifying resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia (CML).